← Eichor
Study identifier: NCT02448485 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)

Condition: Aortic Stenosis · Heart Failure · Syncope  ·  Sponsor: Medical University Innsbruck

PhaseN/A
Planned participants10000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.

This description comes directly from the study's public registry record.

Talk to the study team

Wolfgang Dichtl, MD, PhD  ·  004351250481388  ·  dichtl@me.com

Fabian Barbieri  ·  00436642042968  ·  fabian.barbieri@i-med.ac.at

Always discuss trial participation with your own doctor first.

Locations (1)

Medical University InnsbruckInnsbruck, Tyrol, AustriaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02448485